In the middle and late 1980s, cardiac interventional stent surgery began to enter China. At that time, the stents were all imported products, and the unit price was 20,000 ~ 30,000 yuan. 1999, the heart stent developed in China was successfully listed, and the price dropped to about 1 10,000 yuan, breaking the import monopoly in one fell swoop.
However, there are still few domestic products in clinical cerebrovascular stents. Among them, carotid artery stent mainly depends on imports, while intracranial artery stent has only one domestic brand.
According to the data of the General Administration of Customs of China, in 20 16, the total amount of vascular stents imported from China was 472,878,800 dollars. In the field of coronary stents, the market share of imported stents is about 34%.
The proportion of domestic stents is increasing, and the market share has reached 60%, especially in cardiac interventional therapy, about 80% of cardiac stents are made in China. However, the market of supporting medical devices such as catheters and guide wires is still monopolized by foreign brands.
/iknow-pic . cdn . BCE Bos . com/faf2b 2 1 193 13 b 07 ed9 a 92 16d 03d 79 1 2397 DD 8 CBA " target = " _ blank " title = " " class = " ikqb _ img _ alink " >/iknow-pic . cdn . BCE Bos . com/faf2b 2 1 193 1 3b 07 ed9 a 92 16d 03d 79 12397 DD 8 CBA？ x-BCE-process = image % 2f resize % 2Cm _ lfit % 2Cw _ 600% 2Ch _ 800% 2c limit _ 1% 2f quality % 2Cq _ 85% 2f format % 2Cf _ auto " esrc = "/ n 1/20 17/032 1/c 14739-29 157593